# Hepatitis B Vaccination in Infants

> **NCT01896596** · PHASE4 · COMPLETED · sponsor: **Public Health England** · enrollment: 300 (actual)

## Conditions studied

- Meningococcal Disease
- Pneumococcal Disease
- Haemophilus Influenzae Serotype b Disease
- Diphtheria, Tetanus and Pertussis
- Hepatitis b

## Interventions

- **BIOLOGICAL:** Menjugate
- **BIOLOGICAL:** Menitorix
- **BIOLOGICAL:** NeisVac-C

## Key facts

- **NCT ID:** NCT01896596
- **Lead sponsor:** Public Health England
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2020-10-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01896596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01896596, "Hepatitis B Vaccination in Infants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01896596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*